What Does “Half-Life” Mean for Peptides?

The definition

If a drug has a half-life of one day and you have 100 units of it in your body this morning, you will have about 50 tomorrow, 25 the next day, 12.5 the day after, and so on. The amount never technically reaches zero, but after about five half-lives it is down to roughly 3% of the starting amount, which is usually treated as gone.

Half-life depends on two things: how fast the body clears the drug (through the kidneys, the liver, or enzymes in the blood) and how widely the drug spreads into tissues. Peptides are usually cleared quickly because enzymes chop them up and the kidneys filter them out.

Why natural peptide hormones disappear fast

The body’s own GLP-1 is released after a meal and broken down within about two minutes by an enzyme called DPP-4. GIP lasts about five to seven minutes. Glucagon, about three to six. That speed is a feature in a hormone: the signal switches off as soon as it is no longer needed.

It is a problem in a drug. A GLP-1 injection that vanished in two minutes would be useless. The first GLP-1 drug, exenatide, was based on a lizard peptide that resists DPP-4 and lasts about 2.4 hours, so it had to be injected twice a day.

How weekly peptides are built to last

Semaglutide, tirzepatide, and retatrutide use the same set of tricks:

1. Swap the amino acid DPP-4 attacks. Changing one building block near the start of the chain stops the enzyme from cutting it.
2. Attach a fatty acid chain. The chain lets the peptide bind to albumin, the most abundant protein in blood. Bound to albumin, the drug is too large for the kidneys to filter and is protected from enzymes. It slowly unbinds, so a small fraction is active at any time.
3. Add a spacer. A short linker between the peptide and the fatty acid tunes how tightly it binds to albumin.

Those modifications turn a two-minute hormone into a drug that stays in the body for weeks.

Half-lives of common peptides

Values are from prescribing information or published pharmacokinetic studies and are approximate.

What half-life tells you in practice

What the labels say about dosing

Semaglutide and tirzepatide labels use once-weekly injection schedules, while shorter-acting peptide medicines can use more frequent schedules. Half-life is one pharmacokinetic fact, not a dosing instruction by itself.

How long it takes to reach a steady level

With repeated dosing, drug levels build up until the amount cleared between doses equals the amount added. The Ozempic label says steady-state exposure is reached after 4 to 5 weeks of once-weekly administration. The labels say doses are raised gradually, every 4 weeks, to reduce the risk of gastrointestinal side effects.

How long a drug takes to leave

The Ozempic label says semaglutide remains in the circulation for about 5 weeks after the last dose. The Wegovy label says it remains for about 5 to 7 weeks after the last injectable dose of 2.4 mg or 7.2 mg, or the last oral dose of 25 mg. Both labels say to stop at least 2 months before a planned pregnancy.

What happens with a missed dose

Each label’s missed-dose rules are in the injection sites guide.

Half-life and “research” peptides

Sellers of unapproved peptides sometimes quote half-lives to imply a product is well characterized. A half-life value comes from measuring drug levels in people over time in a controlled study. For a product that has never been through such a study, a quoted half-life is either borrowed from a different product or invented. It says nothing about what is in the vial.